These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26967049)

  • 1. A rank-based transcriptional signature for predicting relapse risk of stage II colorectal cancer identified with proper data sources.
    Zhao W; Chen B; Guo X; Wang R; Chang Z; Dong Y; Song K; Wang W; Qi L; Gu Y; Wang C; Yang D; Guo Z
    Oncotarget; 2016 Apr; 7(14):19060-71. PubMed ID: 26967049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional signatures for coupled predictions of stage II and III colorectal cancer metastasis and fluorouracil-based adjuvant chemotherapy benefit.
    Song K; Guo Y; Wang X; Cai H; Zheng W; Li N; Song X; Ao L; Guo Z; Zhao W
    FASEB J; 2019 Jan; 33(1):151-162. PubMed ID: 29957060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
    Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
    JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer.
    Nguyen MN; Choi TG; Nguyen DT; Kim JH; Jo YH; Shahid M; Akter S; Aryal SN; Yoo JY; Ahn YJ; Cho KM; Lee JS; Choe W; Kang I; Ha J; Kim SS
    Oncotarget; 2015 Oct; 6(31):31674-92. PubMed ID: 26397224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence.
    Alajez NM
    PLoS One; 2016; 11(12):e0167455. PubMed ID: 27935967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular signature for the prediction of recurrence in colorectal cancer.
    Wang L; Shen X; Wang Z; Xiao X; Wei P; Wang Q; Ren F; Wang Y; Liu Z; Sheng W; Huang W; Zhou X; Du X
    Mol Cancer; 2015 Feb; 14(1):22. PubMed ID: 25645394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.
    Chang W; Gao X; Han Y; Du Y; Liu Q; Wang L; Tan X; Zhang Q; Liu Y; Zhu Y; Yu Y; Fan X; Zhang H; Zhou W; Wang J; Fu C; Cao G
    Gut; 2014 Sep; 63(9):1457-67. PubMed ID: 24173294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of genetic signature and TNM staging system for predicting the relapse of locally advanced colorectal cancer.
    Peng J; Wang Z; Chen W; Ding Y; Wang H; Huang H; Huang W; Cai S
    Int J Colorectal Dis; 2010 Nov; 25(11):1277-85. PubMed ID: 20706727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two novel qualitative transcriptional signatures robustly applicable to non-research-oriented colorectal cancer samples with low-quality RNA.
    Cheng J; Guo Y; Guan G; Huang H; Jiang F; He J; Wu J; Guo Z; Liu X; Ao L
    J Cell Mol Med; 2021 Apr; 25(7):3622-3633. PubMed ID: 33719152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
    Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
    Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes.
    Wang K; Song K; Ma Z; Yao Y; Liu C; Yang J; Xiao H; Zhang J; Zhang Y; Zhao W
    Br J Cancer; 2020 Aug; 123(3):410-417. PubMed ID: 32435058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors.
    Kopetz S; Tabernero J; Rosenberg R; Jiang ZQ; Moreno V; Bachleitner-Hofmann T; Lanza G; Stork-Sloots L; Maru D; Simon I; Capellà G; Salazar R
    Oncologist; 2015 Feb; 20(2):127-33. PubMed ID: 25561511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of 42 Genes Linked to Stage II Colorectal Cancer Metastatic Relapse.
    Al-Temaimi RA; Tan TZ; Marafie MJ; Thiery JP; Quirke P; Al-Mulla F
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27136531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying primary site of lung-limited Cancer of unknown primary based on relative gene expression orderings.
    Li M; Li H; Hong G; Tang Z; Liu G; Lin X; Lin M; Qi L; Guo Z
    BMC Cancer; 2019 Jan; 19(1):67. PubMed ID: 30642283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.
    Lehmann BD; Ding Y; Viox DJ; Jiang M; Zheng Y; Liao W; Chen X; Xiang W; Yi Y
    BMC Cancer; 2015 Mar; 15():179. PubMed ID: 25886164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer.
    Guan Q; Yan H; Chen Y; Zheng B; Cai H; He J; Song K; Guo Y; Ao L; Liu H; Zhao W; Wang X; Guo Z
    BMC Genomics; 2018 Jan; 19(1):99. PubMed ID: 29378509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer.
    Cai H; Li X; Li J; Ao L; Yan H; Tong M; Guan Q; Li M; Guo Z
    Oncotarget; 2015 Dec; 6(42):44593-608. PubMed ID: 26527319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer.
    Salazar R; Roepman P; Capella G; Moreno V; Simon I; Dreezen C; Lopez-Doriga A; Santos C; Marijnen C; Westerga J; Bruin S; Kerr D; Kuppen P; van de Velde C; Morreau H; Van Velthuysen L; Glas AM; Van't Veer LJ; Tollenaar R
    J Clin Oncol; 2011 Jan; 29(1):17-24. PubMed ID: 21098318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of prognosis gene expression signatures in colorectal cancer: a systematic review.
    Sanz-Pamplona R; Berenguer A; Cordero D; Riccadonna S; Solé X; Crous-Bou M; Guinó E; Sanjuan X; Biondo S; Soriano A; Jurman G; Capella G; Furlanello C; Moreno V
    PLoS One; 2012; 7(11):e48877. PubMed ID: 23145004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.